Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
28023
Description
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma Visit: All Visits Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Keywords
Versions (5)
- 11/30/17 11/30/17 -
- 11/30/17 11/30/17 -
- 12/7/17 12/7/17 -
- 12/10/17 12/10/17 -
- 1/4/18 1/4/18 -
Copyright Holder
Prof. Dr. med. Georg Heß
Uploaded on
December 10, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Signature GOAL Trial B-cell Lymphoma NCT02499003
Signature GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Similar models
Signature GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Subject ID
Item
Subject ID
text
confirmation patient information
Item
I have reviewed this eCRF and confirm that, to the best of my knowledge, it accurately reflects the study information obtained for this patient. All entries were made either by me or by a person under my supervision who has signed the Delegation and Signature Log
boolean
Date of signature
Item
Date of signature
date
Name of investigator
Item
Name of investigator
text
No comments